FDA 510(k)

Balanced Knee System TriMax Porous Femoral Components

K号: K253161 · 2025-12-19

决定日期2025-12-19

产品代码MBH

咨询委员会OR 请注意，由于原文中未提供具体的医疗设备监管文本，以下是一个示例翻译，您可以根据实际文本进行调整： --- 产品名称：[产品名称] 公司名称：[公司名称] 根据FDA 510(k)预市场批准程序，[产品名称]已获得批准，用于[产品用途描述]。产品注册号：[注册号] PMA编号：[PMA编号] 临床试验编号（NCT）：[NCT编号] PubMed ID（PMID）：[PMID编号] 更多信息请访问以下链接： [URL] --- 请将上述示例中的[产品名称]、[公司名称]、[注册号]、[PMA编号]、[NCT编号]、[PMID编号]和[URL]替换为实际的文本内容。

决定实质等同

器械摘要

Balanced Knee System TriMax Porous Femoral Components is the device name listed in this FDA 510(k) record. The listed applicant is Ortho Development Corp.. It received FDA 510(k) clearance on 2025-12-19 under 510(k) number K253161. The device is classified under product code MBH. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Balanced Knee System TriMax Porous Femoral Components?

Balanced Knee System TriMax Porous Femoral Components is a medical device that received FDA 510(k) clearance on 2025-12-19. The listed applicant is Ortho Development Corp.. The 510(k) number is K253161.

When did Balanced Knee System TriMax Porous Femoral Components receive FDA 510(k) clearance?

Balanced Knee System TriMax Porous Femoral Components received FDA 510(k) clearance on 2025-12-19, under 510(k) number K253161.

Who is the listed applicant for Balanced Knee System TriMax Porous Femoral Components?

The FDA 510(k) record lists Ortho Development Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Balanced Knee System TriMax Porous Femoral Components?

The FDA product code for Balanced Knee System TriMax Porous Femoral Components is MBH.

列明Ortho Development Corp.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K251052Trivicta® 髋关节假体 K242984BKS 修订系统 K242833Legend® 髋臼杯 K233758Trivicta™ 髋关节假体

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。